Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Retina > Surgeon applicants divided on ideal interview format for retina fellowships
  • Retina

Surgeon applicants divided on ideal interview format for retina fellowships

Rob Oconnell

There is a nuanced balance between the cost advantages of virtual interviews and the enhanced ability to gain a more accurate perception of the program and location offered by in-person interviews for surgical retina fellowship applicants, according to a study that found applicants with mostly or completely virtual interviews experienced lower average expenditures but reported a diminished ability to understand the program and location compared to those participating in in-person interviews.

The study, conducted across 3 vitreoretinal surgery fellowship programs, included a survey distributed via email to all applicants for the 2021-2022 and 2022-2023 application cycles. Overall, 36 out of 151 applicants responded.

Participants were questioned on various aspects, including cost, scheduling burdens, the ability to assess the program, location, and preceptor, as well as the number of applications and interviews completed, and the impact on work and surgical days.

Key findings:

Cost Considerations: The study found that applicants with mostly or completely virtual interviews reported significantly lower average expenditures compared to those with mostly in-person or a combination of virtual and in-person interviews (P < 0.001).

Perception of Programs: Applicants with mostly virtual interviews expressed a lower ability to gain a true perception of the program and its location compared to those with in-person interviews (P = 0.003 and P < 0.001, respectively).

Interview Preferences: When asked about their preferred interview format, participants who interviewed mostly in-person largely favored in-person interviews (72.7%). However, those who interviewed mostly or completely virtually were evenly split between in-person, virtual, and hybrid formats (P = 0.136).

As fellowship programs and institutions grapple with the decision of whether to return to in-person interviews or maintain a virtual format in the long term, the study suggests a complex interplay of factors. While virtual interviews offer cost advantages, in-person interactions provide a more accurate perception of the program and location, potentially leading to greater satisfaction with the in-person format. The findings underscore the need for a careful balance between the financial considerations of virtual interviews and the value of in-person interactions in shaping the overall fellowship experience.

Reference
Besagar S, Patel S, Vajzovic L, et al. Applicant Perceptions of In-Person versus Virtual Interview Format for Surgical Retina Fellowship. J Acad Ophthalmol. 2023;15(2):e271-e275. doi: 10.1055/s-0043-1777415. PMID: 38059192; PMCID: PMC10697792.

Share

Related Content

  • Retina

Aflibercept 8 mg shows comparable IOP safety to 2 mg through 96 weeks

  • Retina

Heidelberg receives FDA clearance for updated SPECTRALIS software

  • Retina

Aflibercept 8 mg demonstrates favorable safety profile in large nAMD cohort

  • Retina

Aflibercept 8 mg shows modest benefits in difficult-to-treat nAMD cases

  • Retina

AXPAXLI meets superiority endpoint in SOL-1 Phase 3 wet AMD trial

  • Diabetic Macular Edema

Hawaiian Eye Meeting update: TKI therapy may reduce treatment burden in DME and wet AMD

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon